dipotassium;acetic acid;4-bromo-2-fluoro-1-nitrobenzene;6-bromo-2-methyl-1-propan-2-ylbenzimidazole;5-bromo-2-nitro-N-propan-2-ylaniline;4-bromo-2-N-propan-2-ylbenzene-1,2-diamine;6-(2-chloropyrimidin-4-yl)-2-methyl-1-propan-2-ylbenzimidazole;hydride;methane;2-methyl-1-propan-2-yl-6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzimidazole;oxido formate;oxolane

C75H98BBr4ClFK2N13O12 — CID 161015093

IUPACdipotassium;acetic acid;4-bromo-2-fluoro-1-nitrobenzene;6-bromo-2-methyl-1-propan-2-ylbenzimidazole;5-bromo-2-nitro-N-propan-2-ylaniline;4-bromo-2-N-propan-2-ylbenzene-1,2-diamine;6-(2-chloropyrimidin-4-yl)-2-methyl-1-propan-2-ylbenzimidazole;hydride;methane;2-methyl-1-propan-2-yl-6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzimidazole;oxido formate;oxolane
SMILESC.C1CCOC1.CC(=O)O.CC(C)Nc1cc(Br)ccc1N.CC(C)Nc1cc(Br)ccc1[N+](=O)[O-].Cc1nc2ccc(-c3ccnc(Cl)n3)cc2n1C(C)C.Cc1nc2ccc(B3OC(C)(C)C(C)(C)O3)cc2n1C(C)C.Cc1nc2ccc(Br)cc2n1C(C)C.O=CO[O-].O=[N+]([O-])c1ccc(Br)cc1F.[H-].[K+].[K+]
InChIInChI=1S/C17H25BN2O2.C15H15ClN4.C11H13BrN2.C9H11BrN2O2.C9H13BrN2.C6H3BrFNO2.C4H8O.C2H4O2.CH2O3.CH4.2K.H/c1-11(2)20-12(3)19-14-9-8-13(10-15(14)20)18-21-16(4,5)17(6,7)22-18;1-9(2)20-10(3)18-13-5-4-11(8-14(13)20)12-6-7-17-15(16)19-12;1-7(2)14-8(3)13-10-5-4-9(12)6-11(10)14;1-6(2)11-8-5-7(10)3-4-9(8)12(13)14;1-6(2)12-9-5-7(10)3-4-8(9)11;7-4-1-2-6(9(10)11)5(8)3-4;1-2-4-5-3-1;1-2(3)4;2-1-4-3;;;;/h8-11H,1-7H3;4-9H,1-3H3;4-7H,1-3H3;3-6,11H,1-2H3;3-6,12H,11H2,1-2H3;1-3H;1-4H2;1H3,(H,3,4);1,3H;1H4;;;/q;;;;;;;;;;2*+1;-1/p-1
InChIKeyPSJOXZWMSQIILE-UHFFFAOYSA-M
MW1836.76 g/mol
LogP13.55
Rot. Bonds12

About dipotassium;acetic acid;4-bromo-2-fluoro-1-nitrobenzene;6-bromo-2-methyl-1-propan-2-ylbenzimidazole;5-bromo-2-nitro-N-propan-2-ylaniline;4-bromo-2-N-propan-2-ylbenzene-1,2-diamine;6-(2-chloropyrimidin-4-yl)-2-methyl-1-propan-2-ylbenzimidazole;hydride;methane;2-methyl-1-propan-2-yl-6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzimidazole;oxido formate;oxolane

dipotassium;acetic acid;4-bromo-2-fluoro-1-nitrobenzene;6-bromo-2-methyl-1-propan-2-ylbenzimidazole;5-bromo-2-nitro-N-propan-2-ylaniline;4-bromo-2-N-propan-2-ylbenzene-1,2-diamine;6-(2-chloropyrimidin-4-yl)-2-methyl-1-propan-2-ylbenzimidazole;hydride;methane;2-methyl-1-propan-2-yl-6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzimidazole;oxido formate;oxolane (PubChem CID 161015093) has the molecular formula C75H98BBr4ClFK2N13O12 and a molecular weight of 1836.76 g/mol. Its IUPAC name is dipotassium;acetic acid;4-bromo-2-fluoro-1-nitrobenzene;6-bromo-2-methyl-1-propan-2-ylbenzimidazole;5-bromo-2-nitro-N-propan-2-ylaniline;4-bromo-2-N-propan-2-ylbenzene-1,2-diamine;6-(2-chloropyrimidin-4-yl)-2-methyl-1-propan-2-ylbenzimidazole;hydride;methane;2-methyl-1-propan-2-yl-6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzimidazole;oxido formate;oxolane.

Molecular Properties

Compound Namedipotassium;acetic acid;4-bromo-2-fluoro-1-nitrobenzene;6-bromo-2-methyl-1-propan-2-ylbenzimidazole;5-bromo-2-nitro-N-propan-2-ylaniline;4-bromo-2-N-propan-2-ylbenzene-1,2-diamine;6-(2-chloropyrimidin-4-yl)-2-methyl-1-propan-2-ylbenzimidazole;hydride;methane;2-methyl-1-propan-2-yl-6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzimidazole;oxido formate;oxolane
PubChem CID161015093
Molecular FormulaC75H98BBr4ClFK2N13O12
Molecular Weight1836.76 g/mol
Exact Mass1831.32
IUPAC Namedipotassium;acetic acid;4-bromo-2-fluoro-1-nitrobenzene;6-bromo-2-methyl-1-propan-2-ylbenzimidazole;5-bromo-2-nitro-N-propan-2-ylaniline;4-bromo-2-N-propan-2-ylbenzene-1,2-diamine;6-(2-chloropyrimidin-4-yl)-2-methyl-1-propan-2-ylbenzimidazole;hydride;methane;2-methyl-1-propan-2-yl-6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzimidazole;oxido formate;oxolane
SMILESC.C1CCOC1.CC(=O)O.CC(C)Nc1cc(Br)ccc1N.CC(C)Nc1cc(Br)ccc1[N+](=O)[O-].Cc1nc2ccc(-c3ccnc(Cl)n3)cc2n1C(C)C.Cc1nc2ccc(B3OC(C)(C)C(C)(C)O3)cc2n1C(C)C.Cc1nc2ccc(Br)cc2n1C(C)C.O=CO[O-].O=[N+]([O-])c1ccc(Br)cc1F.[H-].[K+].[K+]
InChIInChI=1S/C17H25BN2O2.C15H15ClN4.C11H13BrN2.C9H11BrN2O2.C9H13BrN2.C6H3BrFNO2.C4H8O.C2H4O2.CH2O3.CH4.2K.H/c1-11(2)20-12(3)19-14-9-8-13(10-15(14)20)18-21-16(4,5)17(6,7)22-18;1-9(2)20-10(3)18-13-5-4-11(8-14(13)20)12-6-7-17-15(16)19-12;1-7(2)14-8(3)13-10-5-4-9(12)6-11(10)14;1-6(2)11-8-5-7(10)3-4-9(8)12(13)14;1-6(2)12-9-5-7(10)3-4-8(9)11;7-4-1-2-6(9(10)11)5(8)3-4;1-2-4-5-3-1;1-2(3)4;2-1-4-3;;;;/h8-11H,1-7H3;4-9H,1-3H3;4-7H,1-3H3;3-6,11H,1-2H3;3-6,12H,11H2,1-2H3;1-3H;1-4H2;1H3,(H,3,4);1,3H;1H4;;;/q;;;;;;;;;;2*+1;-1/p-1
InChIKeyPSJOXZWMSQIILE-UHFFFAOYSA-M
XLogP13.55
TPSA329.95 Ų
H-Bond Donors4
H-Bond Acceptors22
Rotatable Bonds12
Heavy Atoms109
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5001836.76
LogP ≤ 513.55
H-Bond Donors ≤ 54
H-Bond Acceptors ≤ 1022

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'aldehyde', 'substructure': 'N/A'}, {'alert_name': 'aniline', 'substructure': 'N/A'}, {'alert_name': 'heavy_metal', 'substructure': 'N/A'}, {'alert_name': 'nitro_group', 'substructure': 'N/A'}, {'alert_name': 'Oxygen-nitrogen_single_bond', 'substructure': 'N/A'}

Analyze dipotassium;acetic acid;4-bromo-2-fluoro-1-nitrobenzene;6-bromo-2-methyl-1-propan-2-ylbenzimidazole;5-bromo-2-nitro-N-propan-2-ylaniline;4-bromo-2-N-propan-2-ylbenzene-1,2-diamine;6-(2-chloropyrimidin-4-yl)-2-methyl-1-propan-2-ylbenzimidazole;hydride;methane;2-methyl-1-propan-2-yl-6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzimidazole;oxido formate;oxolane with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of dipotassium;acetic acid;4-bromo-2-fluoro-1-nitrobenzene;6-bromo-2-methyl-1-propan-2-ylbenzimidazole;5-bromo-2-nitro-N-propan-2-ylaniline;4-bromo-2-N-propan-2-ylbenzene-1,2-diamine;6-(2-chloropyrimidin-4-yl)-2-methyl-1-propan-2-ylbenzimidazole;hydride;methane;2-methyl-1-propan-2-yl-6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzimidazole;oxido formate;oxolane?
The IUPAC name of dipotassium;acetic acid;4-bromo-2-fluoro-1-nitrobenzene;6-bromo-2-methyl-1-propan-2-ylbenzimidazole;5-bromo-2-nitro-N-propan-2-ylaniline;4-bromo-2-N-propan-2-ylbenzene-1,2-diamine;6-(2-chloropyrimidin-4-yl)-2-methyl-1-propan-2-ylbenzimidazole;hydride;methane;2-methyl-1-propan-2-yl-6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzimidazole;oxido formate;oxolane (CID 161015093) is dipotassium;acetic acid;4-bromo-2-fluoro-1-nitrobenzene;6-bromo-2-methyl-1-propan-2-ylbenzimidazole;5-bromo-2-nitro-N-propan-2-ylaniline;4-bromo-2-N-propan-2-ylbenzene-1,2-diamine;6-(2-chloropyrimidin-4-yl)-2-methyl-1-propan-2-ylbenzimidazole;hydride;methane;2-methyl-1-propan-2-yl-6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzimidazole;oxido formate;oxolane.
What is the SMILES notation for dipotassium;acetic acid;4-bromo-2-fluoro-1-nitrobenzene;6-bromo-2-methyl-1-propan-2-ylbenzimidazole;5-bromo-2-nitro-N-propan-2-ylaniline;4-bromo-2-N-propan-2-ylbenzene-1,2-diamine;6-(2-chloropyrimidin-4-yl)-2-methyl-1-propan-2-ylbenzimidazole;hydride;methane;2-methyl-1-propan-2-yl-6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzimidazole;oxido formate;oxolane?
The canonical SMILES for dipotassium;acetic acid;4-bromo-2-fluoro-1-nitrobenzene;6-bromo-2-methyl-1-propan-2-ylbenzimidazole;5-bromo-2-nitro-N-propan-2-ylaniline;4-bromo-2-N-propan-2-ylbenzene-1,2-diamine;6-(2-chloropyrimidin-4-yl)-2-methyl-1-propan-2-ylbenzimidazole;hydride;methane;2-methyl-1-propan-2-yl-6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzimidazole;oxido formate;oxolane is C.C1CCOC1.CC(=O)O.CC(C)Nc1cc(Br)ccc1N.CC(C)Nc1cc(Br)ccc1[N+](=O)[O-].Cc1nc2ccc(-c3ccnc(Cl)n3)cc2n1C(C)C.Cc1nc2ccc(B3OC(C)(C)C(C)(C)O3)cc2n1C(C)C.Cc1nc2ccc(Br)cc2n1C(C)C.O=CO[O-].O=[N+]([O-])c1ccc(Br)cc1F.[H-].[K+].[K+].
What is the InChIKey of dipotassium;acetic acid;4-bromo-2-fluoro-1-nitrobenzene;6-bromo-2-methyl-1-propan-2-ylbenzimidazole;5-bromo-2-nitro-N-propan-2-ylaniline;4-bromo-2-N-propan-2-ylbenzene-1,2-diamine;6-(2-chloropyrimidin-4-yl)-2-methyl-1-propan-2-ylbenzimidazole;hydride;methane;2-methyl-1-propan-2-yl-6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzimidazole;oxido formate;oxolane?
The InChIKey is PSJOXZWMSQIILE-UHFFFAOYSA-M. The full InChI is InChI=1S/C17H25BN2O2.C15H15ClN4.C11H13BrN2.C9H11BrN2O2.C9H13BrN2.C6H3BrFNO2.C4H8O.C2H4O2.CH2O3.CH4.2K.H/c1-11(2)20-12(3)19-14-9-8-13(10-15(14)20)18-21-16(4,5)17(6,7)22-18;1-9(2)20-10(3)18-13-5-4-11(8-14(13)20)12-6-7-17-15(16)19-12;1-7(2)14-8(3)13-10-5-4-9(12)6-11(10)14;1-6(2)11-8-5-7(10)3-4-9(8)12(13)14;1-6(2)12-9-5-7(10)3-4-8(9)11;7-4-1-2-6(9(10)11)5(8)3-4;1-2-4-5-3-1;1-2(3)4;2-1-4-3;;;;/h8-11H,1-7H3;4-9H,1-3H3;4-7H,1-3H3;3-6,11H,1-2H3;3-6,12H,11H2,1-2H3;1-3H;1-4H2;1H3,(H,3,4);1,3H;1H4;;;/q;;;;;;;;;;2*+1;-1/p-1.
What are the key properties of dipotassium;acetic acid;4-bromo-2-fluoro-1-nitrobenzene;6-bromo-2-methyl-1-propan-2-ylbenzimidazole;5-bromo-2-nitro-N-propan-2-ylaniline;4-bromo-2-N-propan-2-ylbenzene-1,2-diamine;6-(2-chloropyrimidin-4-yl)-2-methyl-1-propan-2-ylbenzimidazole;hydride;methane;2-methyl-1-propan-2-yl-6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzimidazole;oxido formate;oxolane?
dipotassium;acetic acid;4-bromo-2-fluoro-1-nitrobenzene;6-bromo-2-methyl-1-propan-2-ylbenzimidazole;5-bromo-2-nitro-N-propan-2-ylaniline;4-bromo-2-N-propan-2-ylbenzene-1,2-diamine;6-(2-chloropyrimidin-4-yl)-2-methyl-1-propan-2-ylbenzimidazole;hydride;methane;2-methyl-1-propan-2-yl-6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzimidazole;oxido formate;oxolane has a molecular weight of 1836.76 g/mol, XLogP of 13.55, 12 rotatable bonds, 4 hydrogen bond donors, and 22 hydrogen bond acceptors.
Where does this data come from?
All data for dipotassium;acetic acid;4-bromo-2-fluoro-1-nitrobenzene;6-bromo-2-methyl-1-propan-2-ylbenzimidazole;5-bromo-2-nitro-N-propan-2-ylaniline;4-bromo-2-N-propan-2-ylbenzene-1,2-diamine;6-(2-chloropyrimidin-4-yl)-2-methyl-1-propan-2-ylbenzimidazole;hydride;methane;2-methyl-1-propan-2-yl-6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzimidazole;oxido formate;oxolane is sourced from PubChem (CID 161015093), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).